Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A (Q80070150)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 March 2007

Language	Label	Description	Also known as
English	Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A	scientific article published on 29 March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

based on heuristic

inferred from title

author name string

Pauline Wimberger

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Nils Lehmann

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Rainer Kimmig

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Alexander Burges

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Werner Meier

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Andreas Du Bois

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

29 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

106

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

69-74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

The relative importance of surgical training and laboratory research in a gynecologic oncology fellowship

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

The surgical management of women with ovarian cancer in the south west of England

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

The role of surgery in advanced and recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Role of surgery in ovarian cancer: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.026

7 January 2021

Identifiers

10.1016/J.YGYNO.2007.02.026

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17397910%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80070150&oldid=2102136313"